β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins.
β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins.
复制标题
DOI:
10.1016/j.jbc.2021.101375
复制
发表时间:
2021-12
期刊:
影响因子:
--
通讯作者:
Buchman VL
中科院分区:
文献类型:
--
作者:
Ninkina N;Millership SJ;Peters OM;Connor-Robson N;Chaprov K;Kopylov AT;Montoya A;Kramer H;Withers DJ;Buchman VL
Synucleins, a family of three proteins highly expressed in neurons, are predominantly known for the direct involvement of α-synuclein in the etiology and pathogenesis of Parkinson's and certain other neurodegenerative diseases, but their precise physiological functions are still not fully understood. Previous studies have demonstrated the importance of α-synuclein as a modulator of various mechanisms implicated in chemical neurotransmission, but information concerning the involvement of other synuclein family members, β-synuclein and γ-synuclein, in molecular processes within presynaptic terminals is limited. Here, we demonstrated that the vesicular monoamine transporter 2–dependent dopamine uptake by synaptic vesicles isolated from the striatum of mice lacking β-synuclein is significantly reduced. Reciprocally, reintroduction, either in vivo or in vitro, of β-synuclein but not α-synuclein or γ-synuclein improves uptake by triple α/β/γ-synuclein–deficient striatal vesicles. We also showed that the resistance of dopaminergic neurons of the substantia nigra pars compacta to subchronic administration of the Parkinson's disease–inducing prodrug 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine depends on the presence of β-synuclein but only when one or both other synucleins are absent. Furthermore, proteomic analysis of synuclein-deficient synaptic vesicles versus those containing only β-synuclein revealed differences in their protein compositions. We suggest that the observed potentiation of dopamine uptake by β-synuclein might be caused by different protein architecture of the synaptic vesicles. It is also feasible that such structural changes improve synaptic vesicle sequestration of 1-methyl-4-phenylpyridinium, a toxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which would explain why dopaminergic neurons expressing β-synuclein and lacking α-synuclein and/or γ-synuclein are resistant to this neurotoxin.
登录
查看更多内容
影响因子:
6.1
作者:
Klivenyi, P;Siwek, D;Beal, MF
通讯作者:
Beal, MF
影响因子:
4.6
作者:
Kopylov AT;Papysheva O;Gribova I;Kotaysch G;Kharitonova L;Mayatskaya T;Sokerina E;Kaysheva AL;Morozov SG
通讯作者:
Morozov SG
影响因子:
3.4
作者:
Burre, Jacqueline;Beckhaus, Tobias;Volknandt, Walter
通讯作者:
Volknandt, Walter
影响因子:
3.5
作者:
JAKES, R;SPILLANTINI, MG;GOEDERT, M
通讯作者:
GOEDERT, M
DOI:
10.1523/jneurosci.6194-10.2011
发表时间:
2011-05-18
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Anwar S;Peters O;Millership S;Ninkina N;Doig N;Connor-Robson N;Threlfell S;Kooner G;Deacon RM;Bannerman DM;Bolam JP;Chandra SS;Cragg SJ;Wade-Martins R;Buchman VL
通讯作者:
Buchman VL